866-997-4948(US-Canada Toll Free)

Global AT1 Receptor Antagonists Market Insights,Forecast to 2025

Published By :

QYResearch

Published Date : Oct 2018

Category :

Pharmaceutical

No. of Pages : 119 Pages

AT1receptor antagonists are a group of pharmaceuticals that modulate thereninangiotensin system. Their main uses are in the treatment ofhypertension(high blood pressure),diabetic nephropathy(kidney damage due todiabetes) andcongestive heart failure. Theyblockthe activation ofAT1receptors, preventing thebindingofangiotensin II.
In 2017, the global AT1 Receptor Antagonists market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the AT1 Receptor Antagonists market based on company, product type, application and key regions.

This report studies the global market size of AT1 Receptor Antagonists in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of AT1 Receptor Antagonists in these regions.
This research report categorizes the global AT1 Receptor Antagonists market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of AT1 Receptor Antagonists include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the AT1 Receptor Antagonists include
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly and Company
Sanofi SA
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical

Market Size Split by Type
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
Market Size Split by Application
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global AT1 Receptor Antagonists market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of AT1 Receptor Antagonists market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global AT1 Receptor Antagonists manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the AT1 Receptor Antagonists with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of AT1 Receptor Antagonists submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of AT1 Receptor Antagonists are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of AT1 Receptor Antagonists market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 AT1 Receptor Antagonists Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global AT1 Receptor Antagonists Market Size Growth Rate by Type
1.4.2 Valsartan
1.4.3 Telmisartan
1.4.4 Losartan
1.4.5 Irbesartan
1.4.6 Azilsartan
1.4.7 Olmesartan
1.5 Market by Application
1.5.1 Global AT1 Receptor Antagonists Market Size Growth Rate by Application
1.5.2 Hypertension
1.5.3 Cardiovascular Diseases
1.5.4 Kidney Diseases
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global AT1 Receptor Antagonists Market Size
2.1.1 Global AT1 Receptor Antagonists Revenue 2016-2025
2.1.2 Global AT1 Receptor Antagonists Sales 2016-2025
2.2 AT1 Receptor Antagonists Growth Rate by Regions
2.2.1 Global AT1 Receptor Antagonists Sales by Regions
2.2.2 Global AT1 Receptor Antagonists Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 AT1 Receptor Antagonists Sales by Manufacturers
3.1.1 AT1 Receptor Antagonists Sales by Manufacturers
3.1.2 AT1 Receptor Antagonists Sales Market Share by Manufacturers
3.1.3 Global AT1 Receptor Antagonists Market Concentration Ratio (CR5 and HHI)
3.2 AT1 Receptor Antagonists Revenue by Manufacturers
3.2.1 AT1 Receptor Antagonists Revenue by Manufacturers (2016-2018)
3.2.2 AT1 Receptor Antagonists Revenue Share by Manufacturers (2016-2018)
3.3 AT1 Receptor Antagonists Price by Manufacturers
3.4 AT1 Receptor Antagonists Manufacturing Base Distribution, Product Types
3.4.1 AT1 Receptor Antagonists Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers AT1 Receptor Antagonists Product Category
3.4.3 Date of International Manufacturers Enter into AT1 Receptor Antagonists Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global AT1 Receptor Antagonists Sales by Type
4.2 Global AT1 Receptor Antagonists Revenue by Type
4.3 AT1 Receptor Antagonists Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global AT1 Receptor Antagonists Breakdown Data by Application

6 North America
6.1 North America AT1 Receptor Antagonists by Countries
6.1.1 North America AT1 Receptor Antagonists Sales by Countries
6.1.2 North America AT1 Receptor Antagonists Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America AT1 Receptor Antagonists by Type
6.3 North America AT1 Receptor Antagonists by Application
6.4 North America AT1 Receptor Antagonists by Company

7 Europe
7.1 Europe AT1 Receptor Antagonists by Countries
7.1.1 Europe AT1 Receptor Antagonists Sales by Countries
7.1.2 Europe AT1 Receptor Antagonists Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe AT1 Receptor Antagonists by Type
7.3 Europe AT1 Receptor Antagonists by Application
7.4 Europe AT1 Receptor Antagonists by Company

8 Asia Pacific
8.1 Asia Pacific AT1 Receptor Antagonists by Countries
8.1.1 Asia Pacific AT1 Receptor Antagonists Sales by Countries
8.1.2 Asia Pacific AT1 Receptor Antagonists Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific AT1 Receptor Antagonists by Type
8.3 Asia Pacific AT1 Receptor Antagonists by Application
8.4 Asia Pacific AT1 Receptor Antagonists by Company

9 Central & South America
9.1 Central & South America AT1 Receptor Antagonists by Countries
9.1.1 Central & South America AT1 Receptor Antagonists Sales by Countries
9.1.2 Central & South America AT1 Receptor Antagonists Revenue by Countries
9.1.3 Brazil
9.2 Central & South America AT1 Receptor Antagonists by Type
9.3 Central & South America AT1 Receptor Antagonists by Application
9.4 Central & South America AT1 Receptor Antagonists by Company

10 Middle East and Africa
10.1 Middle East and Africa AT1 Receptor Antagonists by Countries
10.1.1 Middle East and Africa AT1 Receptor Antagonists Sales by Countries
10.1.2 Middle East and Africa AT1 Receptor Antagonists Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa AT1 Receptor Antagonists by Type
10.3 Middle East and Africa AT1 Receptor Antagonists by Application
10.4 Middle East and Africa AT1 Receptor Antagonists by Company

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of AT1 Receptor Antagonists
11.1.4 AT1 Receptor Antagonists Product Description
11.1.5 Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of AT1 Receptor Antagonists
11.2.4 AT1 Receptor Antagonists Product Description
11.2.5 Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of AT1 Receptor Antagonists
11.3.4 AT1 Receptor Antagonists Product Description
11.3.5 Recent Development
11.4 Astra Zeneca
11.4.1 Astra Zeneca Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of AT1 Receptor Antagonists
11.4.4 AT1 Receptor Antagonists Product Description
11.4.5 Recent Development
11.5 Jhonson and Johnson
11.5.1 Jhonson and Johnson Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of AT1 Receptor Antagonists
11.5.4 AT1 Receptor Antagonists Product Description
11.5.5 Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of AT1 Receptor Antagonists
11.6.4 AT1 Receptor Antagonists Product Description
11.6.5 Recent Development
11.7 Sanofi SA
11.7.1 Sanofi SA Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of AT1 Receptor Antagonists
11.7.4 AT1 Receptor Antagonists Product Description
11.7.5 Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of AT1 Receptor Antagonists
11.8.4 AT1 Receptor Antagonists Product Description
11.8.5 Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of AT1 Receptor Antagonists
11.9.4 AT1 Receptor Antagonists Product Description
11.9.5 Recent Development
11.10 GSK
11.10.1 GSK Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of AT1 Receptor Antagonists
11.10.4 AT1 Receptor Antagonists Product Description
11.10.5 Recent Development
11.11 Teva Pharmaceutical

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key AT1 Receptor Antagonists Raw Material
13.1.2 AT1 Receptor Antagonists Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of AT1 Receptor Antagonists
Figure Global AT1 Receptor Antagonists Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global AT1 Receptor Antagonists Production Market Share by Types (Product Category) in 2017
Figure Valsartan Product Picture
Table Major Manufacturers of Valsartan
Figure Telmisartan Product Picture
Table Major Manufacturers of Telmisartan
Figure Losartan Product Picture
Table Major Manufacturers of Losartan
Figure Irbesartan Product Picture
Table Major Manufacturers of Irbesartan
Figure Azilsartan Product Picture
Table Major Manufacturers of Azilsartan
Figure Olmesartan Product Picture
Table Major Manufacturers of Olmesartan
Table Global AT1 Receptor Antagonists Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hypertension
Figure Cardiovascular Diseases
Figure Kidney Diseases
Figure Other
Figure AT1 Receptor Antagonists Report Years Considered
Figure Global AT1 Receptor Antagonists Market Size 2016-2025 (Million US$)
Figure Global AT1 Receptor Antagonists Sales 2016-2025 (K Units)
Table Global AT1 Receptor Antagonists Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global AT1 Receptor Antagonists Sales by Regions 2016-2025 (K Units)
Table Global AT1 Receptor Antagonists Sales Market Share by Regions 2016-2025
Figure Global AT1 Receptor Antagonists Sales Market Share by Regions 2016-2025
Figure 2017 Global AT1 Receptor Antagonists Sales Market Share by Regions
Table Global AT1 Receptor Antagonists Revenue by Regions 2016-2025 (Million US$)
Table Global AT1 Receptor Antagonists Revenue Market Share by Regions 2016-2025
Figure Global AT1 Receptor Antagonists Revenue Market Share by Regions 2016-2025
Figure 2017 Global AT1 Receptor Antagonists Revenue Market Share by Regions
Table Global AT1 Receptor Antagonists Sales by Manufacturers (2016-2018) (K Units)
Table Global AT1 Receptor Antagonists Sales Share by Manufacturers (2016-2018)
Figure Global AT1 Receptor Antagonists Sales Share by Manufacturers in 2017
Table AT1 Receptor Antagonists Revenue by Manufacturers (2016-2018) (Million US$)
Table AT1 Receptor Antagonists Revenue Share by Manufacturers (2016-2018)
Figure AT1 Receptor Antagonists Value Share by Manufacturers in 2017
Table Global AT1 Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers AT1 Receptor Antagonists Price (2016-2018) (USD/Unit)
Table AT1 Receptor Antagonists Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers AT1 Receptor Antagonists Product Category
Table Date of International Manufacturers Enter into AT1 Receptor Antagonists Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global AT1 Receptor Antagonists Sales by Type (2016-2025) (K Units)
Table Global AT1 Receptor Antagonists Sales Share by Type (2016-2025)
Figure Global AT1 Receptor Antagonists Sales Market Share by Type (2016-2025)
Figure Global AT1 Receptor Antagonists Sales Market Share by Type in 2017
Table Global AT1 Receptor Antagonists Revenue by Type (2016-2025) (Million US$)
Table Global AT1 Receptor Antagonists Revenue Share by Type (2016-2025)
Figure Global AT1 Receptor Antagonists Revenue Market Share by Type (2016-2025)
Figure Global AT1 Receptor Antagonists Revenue Market Share by Type in 2017
Table AT1 Receptor Antagonists Price by Type 2013-2018 (USD/Unit)
Table Global AT1 Receptor Antagonists Sales by Application (2016-2025) (K Units)
Table Global AT1 Receptor Antagonists Sales Share by Application (2016-2025)
Figure Global Sales AT1 Receptor Antagonists Market Share by Application (2016-2025)
Figure Global Sales AT1 Receptor Antagonists Market Share by Application (2016-2025)
Figure North America AT1 Receptor Antagonists Sales Growth Rate 2016-2025 (K Units)
Figure North America AT1 Receptor Antagonists Revenue Growth Rate 2016-2025 (Million US$)
Table North America AT1 Receptor Antagonists Sales by Countries (2016-2025) (K Units)
Table North America AT1 Receptor Antagonists Sales Market Share by Countries (2016-2025)
Figure 2017 North America AT1 Receptor Antagonists Sales Market Share by Countries
Table North America AT1 Receptor Antagonists Revenue by Countries (2016-2025) (Million US$)
Table North America AT1 Receptor Antagonists Revenue Market Share by Countries (2016-2025)
Figure 2017 North America AT1 Receptor Antagonists Revenue Market Share by Countries
Figure United States AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure United States AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Canada AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Mexico AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Table North America AT1 Receptor Antagonists Sales by Type (2016-2025) (K Units)
Table North America AT1 Receptor Antagonists Sales Market Share by Type (2016-2025)
Figure 2017 North America AT1 Receptor Antagonists Market Share by Type
Table North America AT1 Receptor Antagonists Sales by Application (2016-2025) (K Units)
Table North America AT1 Receptor Antagonists Sales Market Share by Application (2016-2025)
Figure 2017 North America AT1 Receptor Antagonists Market Share by Application
Table North America AT1 Receptor Antagonists Sales by Company (2016-2018) (K Units)
Table North America AT1 Receptor Antagonists Sales Market Share by Company (2016-2018)
Figure North America AT1 Receptor Antagonists Sales Market Share by Company in 2017
Figure Europe AT1 Receptor Antagonists Sales Growth Rate 2016-2025 (K Units)
Figure Europe AT1 Receptor Antagonists Revenue Growth Rate 2016-2025 (Million US$)
Table Europe AT1 Receptor Antagonists Sales by Countries (2016-2025) (K Units)
Table Europe AT1 Receptor Antagonists Sales Market Share by Countries (2016-2025)
Figure 2017 Europe AT1 Receptor Antagonists Sales Market Share by Countries
Table Europe AT1 Receptor Antagonists Revenue by Countries (2016-2025) (Million US$)
Table Europe AT1 Receptor Antagonists Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe AT1 Receptor Antagonists Revenue Market Share by Countries
Figure Germany AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Germany AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (K Units)
Figure France AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure France AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (K Units)
Figure UK AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure UK AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Italy AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Russia AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Table Europe AT1 Receptor Antagonists Sales by Type (2016-2025) (K Units)
Table Europe AT1 Receptor Antagonists Sales Market Share by Type (2016-2025)
Figure 2017 Europe AT1 Receptor Antagonists Market Share by Type
Table Europe AT1 Receptor Antagonists Sales by Application (2016-2025) (K Units)
Table Europe AT1 Receptor Antagonists Sales Market Share by Application (2016-2025)
Figure 2017 Europe AT1 Receptor Antagonists Market Share by Application
Table Europe AT1 Receptor Antagonists Sales by Company (2016-2018) (K Units)
Table Europe AT1 Receptor Antagonists Sales Market Share by Company (2016-2018)
Figure Europe AT1 Receptor Antagonists Sales Market Share by Company in 2017
Figure Asia Pacific AT1 Receptor Antagonists Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific AT1 Receptor Antagonists Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific AT1 Receptor Antagonists Sales by Countries (2016-2025) (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific AT1 Receptor Antagonists Sales Market Share by Countries
Table Asia Pacific AT1 Receptor Antagonists Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific AT1 Receptor Antagonists Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific AT1 Receptor Antagonists Revenue Market Share by Countries
Figure China AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure China AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Japan AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Korea AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure India AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure India AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Australia AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Philippines AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Thailand AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Singapore AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific AT1 Receptor Antagonists Sales by Type (2016-2025) (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific AT1 Receptor Antagonists Market Share by Type
Table Asia Pacific AT1 Receptor Antagonists Sales by Application (2016-2025) (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific AT1 Receptor Antagonists Market Share by Application
Table Asia Pacific AT1 Receptor Antagonists Sales by Company (2016-2018) (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Market Share by Company (2016-2018)
Figure Asia Pacific AT1 Receptor Antagonists Sales Market Share by Company in 2017
Figure Central & South America AT1 Receptor Antagonists Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America AT1 Receptor Antagonists Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America AT1 Receptor Antagonists Sales by Countries (2016-2025) (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America AT1 Receptor Antagonists Sales Market Share by Countries
Table Central & South America AT1 Receptor Antagonists Revenue by Countries (2016-2025) (Million US$)
Table Central & South America AT1 Receptor Antagonists Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America AT1 Receptor Antagonists Revenue Market Share by Countries
Figure Brazil AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Brazil AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Argentina AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America AT1 Receptor Antagonists Sales by Type (2016-2025) (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America AT1 Receptor Antagonists Market Share by Type
Table Central & South America AT1 Receptor Antagonists Sales by Application (2016-2025) (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America AT1 Receptor Antagonists Market Share by Application
Table Central & South America AT1 Receptor Antagonists Sales by Company (2016-2018) (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Market Share by Company (2016-2018)
Figure Central & South America AT1 Receptor Antagonists Sales Market Share by Company in 2017
Figure Middle East and Africa AT1 Receptor Antagonists Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa AT1 Receptor Antagonists Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa AT1 Receptor Antagonists Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Countries
Table Middle East and Africa AT1 Receptor Antagonists Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Countries
Figure GCC Countries AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Turkey AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Egypt AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure South Africa AT1 Receptor Antagonists Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa AT1 Receptor Antagonists Sales by Type (2016-2025) (K Units)
Table Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa AT1 Receptor Antagonists Market Share by Type
Table Middle East and Africa AT1 Receptor Antagonists Sales by Application (2016-2025) (K Units)
Table Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa AT1 Receptor Antagonists Market Share by Application
Table Middle East and Africa AT1 Receptor Antagonists Sales by Company (2016-2018) (K Units)
Table Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Company (2016-2018)
Figure Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Company in 2017
Table Pfizer Company Details
Table Pfizer AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Merck Company Details
Table Merck AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck Recent Development
Table Astra Zeneca Company Details
Table Astra Zeneca AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Astra Zeneca Recent Development
Table Jhonson and Johnson Company Details
Table Jhonson and Johnson AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Jhonson and Johnson Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Eli Lilly and Company Recent Development
Table Sanofi SA Company Details
Table Sanofi SA AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi SA Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bristol-Myers Squibb Recent Development
Table Bayer Company Details
Table Bayer AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bayer Recent Development
Table GSK Company Details
Table GSK AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GSK Recent Development
Table Teva Pharmaceutical Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table AT1 Receptor Antagonists Value Chain
Table Typical Suppliers of Key AT1 Receptor Antagonists Raw Material
Table AT1 Receptor Antagonists Customers List
Table AT1 Receptor Antagonists Sales Channels
Table AT1 Receptor Antagonists Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *